Gabelli Funds LLC United Therapeutics Corp Transaction History

Gabelli Funds LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$92.74 - $125.82 $278,220 - $377,460	-3,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$79.39 - $115.35 $158,780 - $230,700	-2,000 Reduced 40.0%	3,000 $284,000
Q2 2019 Aug 02, 2019	BUY	$76.06 - $120.81 $380,300 - $604,050	5,000 New	5,000 $390,000
Q1 2019 May 02, 2019	SELL	$107.15 - $126.84 $396,455 - $469,308	-3,700 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$101.14 - $118.31 $101,140 - $118,310	1,000 Added 37.04%	3,700 $419,000
Q1 2018 May 09, 2018	BUY	$107.21 - $151.94 $289,467 - $410,238	2,700 New	2,700 $303,000

672

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.